Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;4(18):336.
doi: 10.21037/atm.2016.09.06.

Treatment strategies according to genotype for chronic hepatitis B in children

Seung Man Cho  1 , Byung-Ho Choe  2
Affiliations
Review

Treatment strategies according to genotype for chronic hepatitis B in children

Seung Man Cho et al. Ann Transl Med. 2016 Sep.

Erratum in

Abstract

This review article was requested by editor-in-chief of this journal as 'pediatric CHB treatment' for the upcoming special issue. The main objective of chronic hepatitis B (CHB) treatment is diminishing the risk of complications related to chronic liver disease. In Asia, there are already some reports about hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) infected children. The key points of treatment in children with CHB infections are selection of which patients to treat and conformation of the optimal therapy time that would reduce viral resistance. The choice of therapy is determined by the district (Western/Eastern), HBV genotype, medical accessibility, and economic state of the country. Newly developed nucleos(t)ide analogues (NAs) are potent in children with CHB. However, to improve therapeutic efficacy, physicians are recommended to follow treatment guidelines and determine the specific genotype in the CHB patient. In this article, the treatment of pediatric CHB is reviewed according to differences in genotype.

Keywords: Children; chronic hepatitis B (CHB); genotype; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010;52:2192-205. 10.1002/hep.23934 - DOI - PubMed
    1. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1-98. 10.1007/s12072-015-9675-4 - DOI - PMC - PubMed
    1. European Association For The Study Of The Liver . EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-85. 10.1016/j.jhep.2012.02.010 - DOI - PubMed
    1. Kao JH, Chen DS. Critical analysis of the immune tolerance phase of chronic HBV infection: natural history and diagnosis. Current Hepatitis Reports 2008;7:5-11. 10.1007/s11901-008-0015-1 - DOI
    1. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007;12:160-7. 10.1016/j.siny.2007.01.013 - DOI - PubMed

LinkOut - more resources